Microsomal codeine N-demethylation: Cosegregation with cytochrome P4503A4 activity

Drug Metabolism and Disposition

Volumn 24, Issue 7, 1996, Pages 761-764

  Caraco, Yoseph ^a,b   Tateishi, Tomonori ^a   Guengerich, F Peter ^a   Wood, Alastair J J ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA NAPHTHOFLAVONE; CODEINE; CYTOCHROME P450; DIETHYLDITHIOCARBAMIC ACID; DRUG METABOLITE; ENZYME ANTIBODY; ERYTHROMYCIN; GESTODENE; IMMUNOGLOBULIN G; KETOCONAZOLE; MICROSOME ENZYME; MORPHINE; NIFEDIPINE; NORCODEINE; QUINIDINE; SULFAPHENAZOLE; TROLEANDOMYCIN;

ARTICLE; CONTROLLED STUDY; DEMETHYLATION; DRUG GLUCURONIDATION; DRUG METABOLISM; DRUG TRANSFORMATION; ENZYME ACTIVITY; HUMAN; HUMAN TISSUE; LIVER METABOLISM; LIVER MICROSOME; PHARMACODYNAMICS; PRIORITY JOURNAL;

ARYL HYDROCARBON HYDROXYLASES; CODEINE; CYTOCHROME P-450 CYP2D6; CYTOCHROME P-450 ENZYME SYSTEM; HUMANS; MICROSOMES, LIVER; MIXED FUNCTION OXYGENASES;

EID: 0029680208     PISSN: 00909556     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. G. Sanfilippo: Contributo sperimentale all' ipotesi della smetilazione della codeine nell' organismo. Inflenze della dose sull' assuefazione alla codeine. assuefazione alla codeine attenuta con somministrazione prolungata di morfina. Boll. Soc. Ital. Biol. Sper. 24, 723-726 (1948).
2. Z. R. Chen, A. A. Somogyi, G. Reynolds, and F. Bochner: Disposition of codeine after single and chronic doses in one poor and seven extensive metabolisers. Eur. J. Clin. Pharmacol. 31, 381-390 (1991).
3. Q. Y. Yue, J. O. Svensson, C. Alm, F. Sjoqvist, and J. Sawe: Codeine O-demethylation co-segregates with polymorphic debrisoquine hydroxylation. Br. J. Clin. Pharmacol. 28, 639-645 (1989).
4. O. Mortimer, K. Persson, M. G. Ladona, D. Spalding, U. M. Zanger, U. A. Meyer, and A. Rane: Polymorphic formation of morphine from codeine in poor and extensive metabolizers of dextromethorphan: Relationship to the presence of immunoidentified cytochrome P-450D1. Clin. Pharmacol. Ther. 47, 27-35 (1990).
5. Q. Y. Yue, J. Hasselstrom, J. O. Svensson, and J. Sawe: Pharmacokinetics of codeine and its metabolites in Caucasians healthy volunteers: comparison between extensive and poor hydroxylators of debrisoquine. Br. J. Clin. Pharmacol. 31, 635-642 (1991).
6. S. H. Sindrup, K. Brosen, P. Bjerring, L. Arendt-Nielsen, U. Larsen, H. R. Angelo, and L. F. Gram: Codeine increases pain thresholds to copper vapor laser stimuli in extensive but not poor metabolizers of sparteine. Clin. Pharmacol. Ther. 49, 686-693 (1991).
7. Y. Caraco, J. R. Sheller, and A. J. J. Wood: Polymorphic drug metabolism and codeine pharmacodynamics. Clin. Res. 41, 204A (abstr.) (1993).
8. S. H. Sindrup, L. Arendt-Nielsen, K. Brosen, P. Bjerring, H. R. Angelo, B. Eriksen, and L. F. Gram: The effect of quinidine on the analgesic effect of codeine. Br. J. Clin. Pharmacol. 42, 587-592 (1992).
9. P. P. Wang, P. Beaune, L. S. Kaminsky, G. A. Dannan, F. F. Kadlubar, D. Larrey, and F. P. Guengerich: Purification and characterization of six cytochrome P-450 isoenzymes from human liver microsomes. Biochemistry 22, 5375-5383 (1983).
10. T. Omura and R. Sato: The carbon monoxide-binding pigment of liver microsomes: evidence for its hemoprotein nature. J. Biol. Chem. 239, 2370-2378 (1964).
11. M. G. Ladona, B. Lindstrom, C. Thyr, P. Dun-Ren, and A. Rane: Differential foetal development of the O- and N-demethylation of codeine and dextromethorphan. Br. J. Clin. Pharmacol. 31, 295-302 (1991).
12. F. P. Guengerich, M. V. Martin, P. H. Beaune, P. H. Kremers, T. Wolff, and D. J. Waxman: Characterization of rat and human liver microsomal cytochrome P450 forms involved in nifedipine oxidation, a prototype for genetic polymorphism in oxidative drug metabolism. J. Biol. Chem. 261, 5051-5060 (1986).
13. F. P. Guengerich: Oxidation of 17α-ethynylestradiol by human liver cytochrome P450. Mol. Pharmacol. 33, 500-508 (1988).
14. F. P. Guengerich: Mechanism-based inactivation of human liver microsomal cytochrome P-450 IIIA4 by gestodene. Chem. Res. Toxicol. 3, 363-371(1990).
15. W. R. Brian, M. A. Sari, M. Iwasaki, T. Shimida, L. S. Kaminsky, and F. P. Guengerich: Catalytic activity of human liver cytochrome P450IIIA4 expressed in Saccharomyces cerevisiae. Biochemistry 29, 1280-1292 (1990).
16. P. Sandhu, Z. Guo, T. Baba, M. V. Martin, R. H. Tukey, and F. P. Guengerich: Expression of modified human cytochrome P450 1A2 in Escherichia Coli: stabilization, purification, spectral characterizarion, and catalytic activities of the enzyme. Arch. Biochem. Biophys. 309, 168-177 (1994).
17. P. Sandhu, T. Baba, and F. P. Guengerich: Expression of modified cytochrome P450 2C10 (2C9) in Escherichia coli, purification, and reconstitution of catalytic activity. Arch. Biochem. Biophys. 306, 443-450 (1993).
18. E. M. J. Gillam, T. Baba, B.-R. Kim, S. Ohmori, and F. P. Guengerich: Expression of modified human cytochrome P450 3A4 in Escherichia coli and purification and reconstitution of the enzyme. Arch. Biochem. Biophys. 305, 123-131 (1993).
19. Y. Funae and S. Imaoka: Simultaneous purification of multiple forms of rat liver microsomal cytochrome P-450 by high-performance liquid chromatography. Biochim. Biophys. Acta 842, 119-132 (1985).
20. T. Shimada, K. S. Misono, and F. P. Guengerich: Human liver microsomal cytochrome P450 Mephenytoin 4-hydroxylase, a prototype of genetic polymorphism in oxidative drug metabolism. Purification and characterization of two similar forms involved in the reaction. J. Biol. Chem. 261, 909-921 (1986).
21. Y. Yasukochi and B. S. S. Masters: Some properties of a detergent-solubilized NADPH-cytochrome c(cytochrome P450) reductase purified by biospecific affinity chromatography. J. Biol. Chem. 251, 5337-5344 (1976).
22. F. P. Guengerich: Analysis and characterization of enzymes. In "Principles and Methods of Toxicology" (A. W. Hayes, ed.), pp. 1259-1313, Raven Press, New York, 1994.
23. K. Lown, J. Kolars, K. Turgeon, R. Merion, S. A. Wrighton, and P. B. Watkins: The erythromycin breath test selectively measures P450IIIA4 in patients with severe liver disease. Clin. Pharmacol. Ther. 51, 229-238 (1992).
24. M. G. Ladona, D. J. M. Spalding, L. Ekman, B. Lindstrom, and A. Rane: Human fetal and adult liver metabolism of ethylmorphine: relation to immunodetected cytochrome P450 PCN and interactions with important fetal corticosteroids. Biochem. Pharmacol. 38, 3147-3155 (1989).
25. J. C. Gorski, D R. Jones, S. A. Wrighton, and S. D. Hall: Characterization of dextromethorphan N-demethylation by human liver microsomes. Contribution of the cytochrome P450 3A (CYP3A) subfamily. Biochem. Pharmacol. 48, 173-182 (1994).
26. F. P. Guengerich: Characterization of human microsomal cytochrome P450 enzymes: Annu. Rev. Pharmacol. Toxicol. 29, 241-264 (1989).
27. P. B. Watkins: Role of cytochromes P450 in drug metabolism and hepatotoxicity. Semin. Liver. Dis. 10, 235-250 (1990).
28. Y. Caraco, J. R. Sheller, and A. J. J. Wood: The effect of rifampin on codeine pharmacokinetics and pharmacodynamics. Clin. Res. 41, 204A (abstr.) (1993).
29. C. Ged, J. M. Rouillon, L. Pichard, J. Combalbert, N. Bressot, P. Bories, H. Michel, P. Beaune, and P. Maurel: The increase in urinary excretion of 6β-hydroxycortisol as a marker of human hepatic cytochrome P450IIIA induction. Br. J. Clin. Pharmacol. 28, 373-387 (1989).